The Paul-Ehrlich-Institut (PEI) in Langen, Germany
The Paul-Ehrlich-Institut (PEI) in Langen, Germany is an internationally renowned institute. PEI was established as the Institute for Sera Research and Serum Testing on June 1, 1896 in Steglitz near Berlin. In 1899 the institute was relocated to Frankfurt at the newly established Royal Institute of Experimental Therapy. PEI has seven specialist divisions: Allergology, Bacteriology, Hematology and Transfusion Medicine, Immunology, Medical Biotechnology, Veterinary Medicine and Virology. Additionally there are divisions for Administration and for General Services. The latter includes Pharmacovigilance, Legal Department and Press and Public Relations.
Among others, the present tasks of the PEI include the granting of marketing authorisations and the batch control of biological and hematological drugs as well as research in these fields. Other responsibilities of the PEI are:
Monitoring of drug risks of drugs for which the institute is responsible
Involvement in the granting of marketing authorisations to scientific field tests of immunological drugs for veterinary use
Involvement in the granting of marketing authorisations for "hi-tech" drugs under the licensing procedures of the European Community
Cooperation in international bodies such as the World Health Organization (WHO) and in human and veterinary drugs committees of the European Community
Finally the institute acts in an advisory capacity for the German Federal Government and other government bodies.
Terms of reference:
1- Foster the ICBS "International Blood Screening Test Evaluation Center" within its structure.
2- Evaluate the performance characteristics of test kits used by blood banks in screening to ensure blood safety, including kits manufactured in developing countries.
3- Assist in the training of scientists from developing countries.